Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6WKA

human carbonic anhydrase II bound to an inhibitor modified with azidothymidine

Summary for 6WKA
Entry DOI10.2210/pdb6wka/pdb
DescriptorCarbonic anhydrase 2, ZINC ION, 3'-deoxy-3'-(4-{[(4-sulfamoylphenyl)amino]methyl}-1H-1,2,3-triazol-1-yl)thymidine, ... (4 entities in total)
Functional Keywordshuman ca ii, inhibitor, click chemistry, azidothymidine, lyase
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight29831.97
Authors
Peat, T.S. (deposition date: 2020-04-15, release date: 2021-02-24, Last modification date: 2023-10-18)
Primary citationBerrino, E.,Angeli, A.,Zhdanov, D.D.,Kiryukhina, A.P.,Milaneschi, A.,De Luca, A.,Bozdag, M.,Carradori, S.,Selleri, S.,Bartolucci, G.,Peat, T.S.,Ferraroni, M.,Supuran, C.T.,Carta, F.
Azidothymidine "Clicked" into 1,2,3-Triazoles: First Report on Carbonic Anhydrase-Telomerase Dual-Hybrid Inhibitors.
J.Med.Chem., 63:7392-7409, 2020
Cited by
PubMed Abstract: Cancer cells rely on the enzyme telomerase (EC 2.7.7.49) to promote cellular immortality. Telomerase inhibitors (i.e., azidothymidine) can represent promising antitumor agents, although showing high toxicity when administered alone. Better outcomes were observed within a multipharmacological approach instead. In this context, we exploited the validated antitumor targets carbonic anhydrases (CAs; EC 4.2.1.1) IX and XII to attain the first proof of concept on CA-telomerase dual-hybrid inhibitors. Compounds , , , and showed good in vitro inhibition potency against the CAs IX and XII, with values in the low nanomolar range, and strong antitelomerase activity in PC-3 and HT-29 cells (IC values ranging from 5.2 to 9.1 μM). High-resolution X-ray crystallography on selected derivatives in the adduct with hCA II as a model study allowed to determine their binding modes and thus to set the structural determinants necessary for further development of compounds selectively targeting the tumoral cells.
PubMed: 32463228
DOI: 10.1021/acs.jmedchem.0c00636
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.34 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon